What does CUSIP 00654J107 represent in this 13F holders report?

CUSIP 00654J107 is the security identifier for ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS in Q2 2022?

5 institutional investors reported ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS for Q2 2022. Use the holders table for investor-level position and value details.

ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN)

CUSIP: 00654J107

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / SPONSORED ADS
Total 13F shares: 1,283,553
Total 13F value: $1,477,000
Share change: +216,719
SEC-reported price per share: $1.15
Number of holders: 5
Value change: -$795,609
Number of buys: 3
Number of sells: 2

Security key

00654J107

Report period

Q2 2022

Institutions

Top holders

ADXN full security history Ownership snapshot Full 13F holder table Addex Therapeutics Ltd. SEC filings Addex Therapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/5

Latest evidence

31 Mar 2022

13F Highest disclosed value: $2,886,000 5 rows are not safely comparable across share classes.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $2.89M.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $2.89M

CAXTON CORP $1.35M

NEA Management Company, LLC $914K

New Leaf Venture Partners, L.L.C. $254K

UBS Group AG $14K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$2,886,000 568,088 shares	—	31 Mar 2022
CAXTON CORP	13F Company 13F	— denominator unverified	$1,351,000 265,940 shares	—	31 Mar 2022
NEA Management Company, LLC	13F Company 13F	— denominator unverified	$914,000 180,000 shares	—	31 Mar 2022
New Leaf Venture Partners, L.L.C.	13F Company 13F	— denominator unverified	$254,000 50,000 shares	—	31 Mar 2022
UBS Group AG	13F Company 13F	— denominator unverified	$14,000 2,806 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,283,553

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q2 2022 value	Value change	Value Chg %